简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-06-19 16:15 Brightree Announces eReferral Integration with athenahealth
2018-06-19 09:47 Clover Biopharmaceuticals Doses First Patient in Australia in Phase I Study of SCB-313 for Malignant Ascites
2018-06-15 15:25 PMI’s Latest Clinical Results: Findings Add to Extensive Evidence Package on Risk Reduction
2018-06-14 15:23 Siemens, PSE to Collaborate on Model-Based Solutions
2018-06-13 14:04 New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
2018-06-11 18:35 Zebra Medical Vision Raises $30M, Unveils the Broadest, Automated AI Based Radiology Chest X-Ray Reader to Date
2018-06-11 18:01 Takeda Announces Term Loan Credit Agreement and Amendment to Bridge Credit Agreement in Connection with Proposed Shire Acquisition
2018-06-11 13:47 Incheon Medical Tourism Offers High-tech Medicine, Easy Access, Convenient Services and Reliable Aftercare
2018-06-07 15:51 Sonion and Valencell Partner to Make Biometrics Universal in Hearables and Hearing Health Markets
2018-06-07 15:47 Sinopharm shows vhf’s Z4 at Sino-Dental
2018-06-07 09:21 PMI’S Latest Scientific Update for Smoke-Free Products Highlights Independent Research
2018-06-06 14:52 New ResMed-sponsored Study Shows Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination
2018-06-05 14:29 New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
2018-06-05 11:03 BRIC INVEST Offers Aimedis – AIM ICO: Leveraging Blockchain and AI for a Sound eHealth Investment
2018-06-05 10:04 Harbour BioMed and The Wistar Institute Join Forces to Advance Novel Antibody Therapies for Cancer and Infectious Diseases
2018-06-04 16:05 Nerviano Medical Sciences Announces Collaboration and License Agreement with Merck to Discover Small Molecule Inhibitors of Certain Anticancer Targets
2018-06-04 09:27 Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab Plus Chemotherapy in Patients with Previously Untreated Follicular Lymphoma to be Presented at ASCO 2018
2018-06-04 09:24 Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the PVd Triplet Improved PFS in Early Lines of Relapsed or Refractory Multiple Myeloma
2018-05-31 18:22 IWBI Launches WELL v2™
2018-05-31 14:58 ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies

Business Wire Weibo

Press Releases

Latest Releases